PFM
ITCI
Privium Fund Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-97,154
| Closed | -$8.11M | – | 68 |
|
2024
Q4 | $8.11M | Sell |
97,154
-20,829
| -18% | -$1.74M | 1.84% | 13 |
|
2024
Q3 | $8.63M | Hold |
117,983
| – | – | 2.15% | 13 |
|
2024
Q2 | $8.09M | Buy |
117,983
+9,100
| +8% | +$624K | 2.06% | 13 |
|
2024
Q1 | $7.53M | Buy |
108,883
+14,900
| +16% | +$1.03M | 2.01% | 15 |
|
2023
Q4 | $6.62M | Buy |
93,983
+333
| +0.4% | +$23.5K | 1.85% | 17 |
|
2023
Q3 | $4.88M | Buy |
93,650
+10,000
| +12% | +$521K | 1.45% | 21 |
|
2023
Q2 | $5.18M | Buy |
+83,650
| New | +$5.18M | 1.49% | 21 |
|